Technology
Vascular Insights received 510(k) clearance from the FDA to market its ClariVein infusion catheter for infusion of physician-specified agents in the peripheral vasculature. ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.
July 08, 2008
News
July 9, 2008 – An article in the July issue of The Journal of Clinical Hypertension indicates an increased intake in ...
July 08, 2008News
July 8, 2008 - Expanding the application of endovascular aortic repair, Medtronic Inc. today announced two major ...
July 07, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026Technology
TRUMPF Medical Systems Inc. offers an in-light high definition (HD) operating room camera, the TruVidia HD, which captures and transmits razor sharp, true-to-life images. The camera offers a 1,080 line horizontal resolution and 2 million pixels. The images are said to be more than twice as clear as those available from standard definition cameras.
July 07, 2008News
July 8, 2008 - The University of Mississippi Medical Center and St. Peter’s Hospital each implemented a suite of IT ...
July 07, 2008News
July 8, 2008 - Foothills Medical Centre, a leading medical centre for treating patients with cardiac rhythm abnormalities in Calgary, Alberta, has become the first facility in Canada to use the new Evolution Mechanical Dilator Sheath Set from Cook Medical for the removal of pacemaker leads, reportedly simplifying this potentially challenging medical procedure.
July 07, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
July 7, 2008 - OrbusNeich today said data recently presented at the 17th Annual Meeting of the Japanese Society of ...
July 06, 2008News
July 7, 2008 - InTouch Technologies Inc. today launched a new product feature, StrokeRESPOND, to extend the ...
July 06, 2008News
July 7, 2008 - The American Academy of Pediatrics (AAP) today issued new cholesterol screening and treatment ...
July 06, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Technology
Boston Scientific Corp. offers the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific.
July 02, 2008News
July 3, 2008 - A multicenter trial with up to five years of follow-up continues to support the mid- and long-term durability and safety of the Zenith endovascular graft used for aneurysm repair.
July 02, 2008News
July 3, 2008 - A unanimous federal jury in Texas recently found that two patents exclusively licensed to Pressure Products Medical Supplies Inc., which cover medical products called valved peel-away introducers used for placement and implantation of pacemaker leads, were valid and infringed by the FlowGuard and ViaSeal products marketed by Quan Emerteq Corp.
July 02, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 2, 2008 - The Society for Cardiovascular Angiography and Interventions (SCAI), the leading professional ...
July 01, 2008News
July 1, 2008 - The impact of surgeons' annual aortic volume and other prognostic indicators have been revealed in early outcomes of ruptured abdominal aortic aneurysm (RAAA) repair in a recent study from the University of Pittsburgh Medical Center. Details of the study have been published in the July issue of the Journal of Vascular Surgery.
July 01, 2008News
July 3, 2008 - Boston Scientific Corp. today said the FDA has approved the PROMUS Everolimus-Eluting Coronary Stent ...
July 01, 2008